Product
PROTOXIN
1 clinical trial
1 indication
Indication
Glabellar Frown LinesClinical trial
A Multicenter, Double-blind, Randomized, Parallel, Active-controlled, Phase III Clinical Trial to Compare the Efficacy and Safety of Protoxin Versus Botox® in Subjects With Moderate to Severe Glabellar LinesStatus: Completed, Estimated PCD: 2023-06-20